Bayamban, Eto H.

HRN: 22-57-27  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/30/2025
CEFTRIAXONE 1G (VIAL)
04/30/2025
05/06/2025
IV
2g
OD
CAP MR
Waiting Final Action 
04/30/2025
AZITHROMYCIN 500MG TABLET (TAB)
04/30/2025
05/04/2025
ORAL
500mg
OD
CAP MR
Waiting Final Action 
05/02/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
05/02/2025
05/09/2025
IV
1.5 Gram
Q12 Hrs
UTI
Waiting Final Action 
05/04/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/04/2025
05/04/2025
IV
4.5g
Now
CAP-MR
Rejected 
05/04/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/04/2025
05/10/2025
IV
2.25g
Q6
CAP-MR
Rejected 
05/07/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/07/2025
05/13/2025
IV
4.5g
Q8H
Complicated UTI (Yeast)
Waiting Final Action 
05/09/2025
FLUCONAZOLE 50MG (CAP)
05/09/2025
05/15/2025
PO
2 Caps
OD
Urine Yeast Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: